25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

IMNN (Imunon) Stock Analysis
Buy, Hold or Sell?

Let's analyze Imunon together

I guess you are interested in Imunon Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Imunon’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Imunon’s Price Targets

I'm going to help you getting a better view of Imunon Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Imunon Inc

I send you an email if I find something interesting about Imunon Inc.

1. Quick Overview

1.1. Quick analysis of Imunon (30 sec.)










1.2. What can you expect buying and holding a share of Imunon? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
5.0%

What is your share worth?

Current worth
$0.29
Expected worth in 1 year
$-0.34
How sure are you?
35.0%

+ What do you gain per year?

Total Gains per Share
$-0.63
Return On Investment
-71.2%

For what price can you sell your share?

Current Price per Share
$0.88
Expected price per share
$0.7609 - $1.39
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Imunon (5 min.)




Live pricePrice per Share (EOD)
$0.88
Intrinsic Value Per Share
$-15,010.51 - $-5,415.67
Total Value Per Share
$-15,010.21 - $-5,415.37

2.2. Growth of Imunon (5 min.)




Is Imunon growing?

Current yearPrevious yearGrowGrow %
How rich?$4.2m$19.9m-$13.7m-222.7%

How much money is Imunon making?

Current yearPrevious yearGrowGrow %
Making money-$1.2b-$21.6m-$1.1b-98.2%
Net Profit Margin-139.5%-17.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Imunon (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Imunon?

Welcome investor! Imunon's management wants to use your money to grow the business. In return you get a share of Imunon.

First you should know what it really means to hold a share of Imunon. And how you can make/lose money.

Speculation

The Price per Share of Imunon is $0.8781. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Imunon.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Imunon, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.29. Based on the TTM, the Book Value Change Per Share is $-0.16 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.27 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Imunon.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.28-31.6%-83.09-9,462.3%-0.33-37.9%-16.95-1,929.8%-8.63-982.9%
Usd Book Value Change Per Share-0.27-30.7%-0.16-17.8%-0.27-31.0%-0.01-1.6%-0.05-5.6%
Usd Dividend Per Share0.000.0%0.000.0%5.38613.1%1.64186.4%0.8293.2%
Usd Total Gains Per Share-0.27-30.7%-0.16-17.8%5.11582.1%1.62184.8%0.7787.6%
Usd Price Per Share0.95-1.20-1.05-1.46-1.62-
Price to Earnings Ratio-0.86--0.74--0.80--0.94--1.13-
Price-to-Total Gains Ratio-3.52--2.13--3.25-0.34-1.25-
Price to Book Ratio3.27-3.13-0.77-1.25-1.51-
Price-to-Total Gains Ratio-3.52--2.13--3.25-0.34-1.25-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.8781
Number of shares1138
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.001.64
Usd Book Value Change Per Share-0.16-0.01
Usd Total Gains Per Share-0.161.62
Gains per Quarter (1138 shares)-177.921,846.67
Gains per Year (1138 shares)-711.677,386.69
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-712-7227449-627377
20-1423-143414898-12514764
30-2135-214622347-18722151
40-2847-285829796-24929538
50-3558-357037245-31236925
60-4270-428244694-37444312
70-4982-499452143-43651699
80-5693-570659592-49959086
90-6405-641867041-56166473
100-7117-713074490-62373860

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.039.00.02.5%3.0111.00.02.6%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%6.014.00.030.0%12.028.00.030.0%38.076.00.033.3%
Dividend per Share0.00.04.00.0%2.00.010.016.7%2.00.018.010.0%2.00.038.05.0%2.00.0112.01.8%
Total Gains per Share1.03.00.025.0%4.08.00.033.3%8.012.00.040.0%14.026.00.035.0%40.074.00.035.1%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Imunon Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.270-0.156-42%-0.273+1%-0.014-95%-0.049-82%
Book Value Per Share--0.2900.422-31%1.361-79%1.948-85%1.551-81%
Current Ratio--0.0021.580-100%3.602-100%4.513-100%3.503-100%
Debt To Asset Ratio--0.5630.504+12%0.319+77%0.377+49%0.498+13%
Debt To Equity Ratio--0.0010.758-100%0.479-100%0.617-100%1.252-100%
Dividend Per Share----0%5.384-100%1.636-100%0.818-100%
Enterprise Value--14289366.00019544467.000-27%28473516.170-50%35836037.035-60%27487279.588-48%
Eps---0.277-83.089+29842%-0.333+20%-16.946+6007%-8.631+3010%
Ev To Ebitda Ratio---0.918-1.082+18%-1.492+63%-2.176+137%-0.789-14%
Ev To Sales Ratio--4.913infnan%infnan%infnan%infnan%
Free Cash Flow Per Share---304.398-76.347-75%-8.050-97%-17.062-94%-8.670-97%
Free Cash Flow To Equity Per Share---304.398-76.192-75%-8.112-97%-16.874-94%-8.472-97%
Gross Profit Margin--1374.928546.033+152%1.007+136411%110.008+1150%55.504+2377%
Intrinsic Value_10Y_max---5415.665--------
Intrinsic Value_10Y_min---15010.505--------
Intrinsic Value_1Y_max---108.367--------
Intrinsic Value_1Y_min---351.598--------
Intrinsic Value_3Y_max---656.601--------
Intrinsic Value_3Y_min---2060.927--------
Intrinsic Value_5Y_max---1603.899--------
Intrinsic Value_5Y_min---4858.064--------
Market Cap12838436.670-8%13889665.00017581391.750-21%15323955.670-9%21976277.735-37%24545516.013-43%
Net Profit Margin---5.580-1.395-75%-0.173-97%-38.795+595%-38.128+583%
Operating Margin---4.592-1.148-75%-0.219-95%-25.876+464%-31.463+585%
Operating Ratio--6.2021.550+300%0.212+2831%26.942-77%34.290-82%
Pb Ratio3.025-8%3.2733.130+5%0.774+323%1.251+162%1.506+117%
Pe Ratio-0.791+8%-0.856-0.740-14%-0.801-6%-0.939+10%-1.129+32%
Price Per Share0.878-8%0.9501.203-21%1.048-9%1.456-35%1.622-41%
Price To Free Cash Flow Ratio-0.001+8%-0.001-0.729+93309%-0.638+81613%-1.141+146190%-1.237+158462%
Price To Total Gains Ratio-3.252+8%-3.519-2.127-40%-3.249-8%0.340-1136%1.254-381%
Quick Ratio--0.0011.632-100%5.034-100%5.934-100%4.914-100%
Return On Assets---0.418-84.488+20136%-0.570+36%-17.104+3996%-8.609+1962%
Return On Equity---0.001-148.342+15518124%-0.884+92384%-29.995+3137704%-15.183+1588257%
Total Gains Per Share---0.270-0.156-42%5.111-105%1.623-117%0.769-135%
Usd Book Value--4244298.0006169249.000-31%19905381.000-79%29006121.250-85%23106575.375-82%
Usd Book Value Change Per Share---0.270-0.156-42%-0.273+1%-0.014-95%-0.049-82%
Usd Book Value Per Share--0.2900.422-31%1.361-79%1.948-85%1.551-81%
Usd Dividend Per Share----0%5.384-100%1.636-100%0.818-100%
Usd Enterprise Value--14289366.00019544467.000-27%28473516.170-50%35836037.035-60%27487279.588-48%
Usd Eps---0.277-83.089+29842%-0.333+20%-16.946+6007%-8.631+3010%
Usd Free Cash Flow---4450510369.000-1116239746.500-75%-117695287.000-97%-249565614.700-94%-126879074.875-97%
Usd Free Cash Flow Per Share---304.398-76.347-75%-8.050-97%-17.062-94%-8.670-97%
Usd Free Cash Flow To Equity Per Share---304.398-76.192-75%-8.112-97%-16.874-94%-8.472-97%
Usd Market Cap12838436.670-8%13889665.00017581391.750-21%15323955.670-9%21976277.735-37%24545516.013-43%
Usd Price Per Share0.878-8%0.9501.203-21%1.048-9%1.456-35%1.622-41%
Usd Profit---4057225.000-1214812441.750+29842%-21603653.000+432%-252093366.100+6113%-128387980.000+3064%
Usd Revenue--727160.000181790.000+300%1762684.500-59%463894.900+57%294447.450+147%
Usd Total Gains Per Share---0.270-0.156-42%5.111-105%1.623-117%0.769-135%
 EOD+3 -5MRQTTM+11 -26YOY+12 -275Y+13 -2610Y+12 -27

3.3 Fundamental Score

Let's check the fundamental score of Imunon Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.791
Price to Book Ratio (EOD)Between0-13.025
Net Profit Margin (MRQ)Greater than0-5.580
Operating Margin (MRQ)Greater than0-4.592
Quick Ratio (MRQ)Greater than10.001
Current Ratio (MRQ)Greater than10.002
Debt to Asset Ratio (MRQ)Less than10.563
Debt to Equity Ratio (MRQ)Less than10.001
Return on Equity (MRQ)Greater than0.15-0.001
Return on Assets (MRQ)Greater than0.05-0.418
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Imunon Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.870
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Imunon Inc

Imunon, Inc., a clinical-stage biotechnology company, develops immunotherapies and next-generation vaccines. The company's lead clinical program IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development. Its preclinical stage products include IMNN-101, a COVID-19 booster vaccine; IMNN-102 for the treatment of Lassa virus; and IMNN-201, a Trp2 tumor associated antigen cancer vaccine in melanoma. In addition, the company develops non-viral DNA technology across four modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; and PlaCCine for the coding of viral antigens that can elicit a strong immunological response. Imunon, Inc. was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. The company was founded in 1982 and is headquartered in Lawrenceville, New Jersey.

Fundamental data was last updated by Penke on 2025-04-05 04:35:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Imunon earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Imunon to theΒ Biotechnology industry mean.
  • A Net Profit Margin of -558.0%Β means thatΒ $-5.58 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Imunon Inc:

  • The MRQ is -558.0%. The company is making a huge loss. -2
  • The TTM is -139.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-558.0%TTM-139.5%-418.5%
TTM-139.5%YOY-17.3%-122.2%
TTM-139.5%5Y-3,879.5%+3,740.0%
5Y-3,879.5%10Y-3,812.8%-66.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-558.0%-100.3%-457.7%
TTM-139.5%-188.1%+48.6%
YOY-17.3%-200.1%+182.8%
5Y-3,879.5%-393.6%-3,485.9%
10Y-3,812.8%-501.9%-3,310.9%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Imunon is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Imunon to theΒ Biotechnology industry mean.
  • -41.8% Return on Assets means thatΒ Imunon generatedΒ $-0.42 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Imunon Inc:

  • The MRQ is -41.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8,448.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-41.8%TTM-8,448.8%+8,407.1%
TTM-8,448.8%YOY-57.0%-8,391.8%
TTM-8,448.8%5Y-1,710.4%-6,738.4%
5Y-1,710.4%10Y-860.9%-849.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-41.8%-12.5%-29.3%
TTM-8,448.8%-12.3%-8,436.5%
YOY-57.0%-12.5%-44.5%
5Y-1,710.4%-13.8%-1,696.6%
10Y-860.9%-15.7%-845.2%
4.3.1.3. Return on Equity

Shows how efficient Imunon is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Imunon to theΒ Biotechnology industry mean.
  • -0.1% Return on Equity means Imunon generated $0.00Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Imunon Inc:

  • The MRQ is -0.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -14,834.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.1%TTM-14,834.2%+14,834.1%
TTM-14,834.2%YOY-88.4%-14,745.8%
TTM-14,834.2%5Y-2,999.5%-11,834.7%
5Y-2,999.5%10Y-1,518.3%-1,481.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.1%-16.1%+16.0%
TTM-14,834.2%-16.2%-14,818.0%
YOY-88.4%-16.1%-72.3%
5Y-2,999.5%-21.0%-2,978.5%
10Y-1,518.3%-22.2%-1,496.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Imunon Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Imunon is operatingΒ .

  • Measures how much profit Imunon makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Imunon to theΒ Biotechnology industry mean.
  • An Operating Margin of -459.2%Β means the company generated $-4.59 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Imunon Inc:

  • The MRQ is -459.2%. The company is operating very inefficient. -2
  • The TTM is -114.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-459.2%TTM-114.8%-344.4%
TTM-114.8%YOY-21.9%-92.9%
TTM-114.8%5Y-2,587.6%+2,472.8%
5Y-2,587.6%10Y-3,146.3%+558.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-459.2%-193.7%-265.5%
TTM-114.8%-286.4%+171.6%
YOY-21.9%-223.4%+201.5%
5Y-2,587.6%-393.8%-2,193.8%
10Y-3,146.3%-475.0%-2,671.3%
4.3.2.2. Operating Ratio

Measures how efficient Imunon is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 6.20 means that the operating costs are $6.20 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Imunon Inc:

  • The MRQ is 6.202. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.550. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ6.202TTM1.550+4.651
TTM1.550YOY0.212+1.339
TTM1.5505Y26.942-25.391
5Y26.94210Y34.290-7.348
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.2022.208+3.994
TTM1.5503.152-1.602
YOY0.2123.121-2.909
5Y26.9425.168+21.774
10Y34.2906.512+27.778
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Imunon Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Imunon is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 0.00Β means the company has $0.00 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Imunon Inc:

  • The MRQ is 0.002. The company is unable to pay all its short-term debts. -2
  • The TTM is 1.580. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ0.002TTM1.580-1.579
TTM1.580YOY3.602-2.021
TTM1.5805Y4.513-2.933
5Y4.51310Y3.503+1.010
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0023.726-3.724
TTM1.5803.930-2.350
YOY3.6024.316-0.714
5Y4.5135.777-1.264
10Y3.5036.144-2.641
4.4.3.2. Quick Ratio

Measures if Imunon is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Imunon to theΒ Biotechnology industry mean.
  • A Quick Ratio of 0.00Β means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Imunon Inc:

  • The MRQ is 0.001. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.632. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ0.001TTM1.632-1.630
TTM1.632YOY5.034-3.403
TTM1.6325Y5.934-4.303
5Y5.93410Y4.914+1.021
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0012.944-2.943
TTM1.6323.417-1.785
YOY5.0344.212+0.822
5Y5.9345.714+0.220
10Y4.9146.434-1.520
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Imunon Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of ImunonΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Imunon to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.56Β means that Imunon assets areΒ financed with 56.3% credit (debt) and the remaining percentage (100% - 56.3%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Imunon Inc:

  • The MRQ is 0.563. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.504. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.563TTM0.504+0.060
TTM0.504YOY0.319+0.185
TTM0.5045Y0.377+0.126
5Y0.37710Y0.498-0.121
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5630.342+0.221
TTM0.5040.343+0.161
YOY0.3190.330-0.011
5Y0.3770.362+0.015
10Y0.4980.387+0.111
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Imunon is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Imunon to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 0.1% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Imunon Inc:

  • The MRQ is 0.001. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.758. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.001TTM0.758-0.757
TTM0.758YOY0.479+0.279
TTM0.7585Y0.617+0.142
5Y0.61710Y1.252-0.635
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0010.402-0.401
TTM0.7580.421+0.337
YOY0.4790.396+0.083
5Y0.6170.446+0.171
10Y1.2520.486+0.766
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Imunon generates.

  • Above 15 is considered overpriced butΒ always compareΒ Imunon to theΒ Biotechnology industry mean.
  • A PE ratio of -0.86 means the investor is paying $-0.86Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Imunon Inc:

  • The EOD is -0.791. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.856. Based on the earnings, the company is expensive. -2
  • The TTM is -0.740. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.791MRQ-0.856+0.065
MRQ-0.856TTM-0.740-0.116
TTM-0.740YOY-0.801+0.062
TTM-0.7405Y-0.939+0.200
5Y-0.93910Y-1.129+0.190
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.791-1.758+0.967
MRQ-0.856-2.592+1.736
TTM-0.740-3.216+2.476
YOY-0.801-3.278+2.477
5Y-0.939-6.457+5.518
10Y-1.129-7.176+6.047
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Imunon Inc:

  • The EOD is -0.001. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.001. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.729. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.001MRQ-0.001+0.000
MRQ-0.001TTM-0.729+0.728
TTM-0.729YOY-0.638-0.091
TTM-0.7295Y-1.141+0.413
5Y-1.14110Y-1.237+0.096
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.001-2.331+2.330
MRQ-0.001-3.585+3.584
TTM-0.729-4.034+3.305
YOY-0.638-4.487+3.849
5Y-1.141-8.803+7.662
10Y-1.237-9.972+8.735
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Imunon is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 3.27 means the investor is paying $3.27Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Imunon Inc:

  • The EOD is 3.025. Based on the equity, the company is fair priced.
  • The MRQ is 3.273. Based on the equity, the company is fair priced.
  • The TTM is 3.130. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.025MRQ3.273-0.248
MRQ3.273TTM3.130+0.143
TTM3.130YOY0.774+2.356
TTM3.1305Y1.251+1.879
5Y1.25110Y1.506-0.255
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.0251.585+1.440
MRQ3.2732.265+1.008
TTM3.1302.441+0.689
YOY0.7742.512-1.738
5Y1.2513.773-2.522
10Y1.5064.294-2.788
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Imunon Inc.

4.8.1. Institutions holding Imunon Inc

Institutions are holding 2.91% of the shares of Imunon Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-12-31Geode Capital Management, LLC0.954201395051357010.7754
2024-12-31BlackRock Inc0.398205822200
2024-12-31Vanguard Group Inc0.333804880600
2024-12-31Royal Bank of Canada0.2742040097400970
2024-12-31Renaissance Technologies Corp0.22950.000133561-30050-47.2403
2024-12-31Northern Trust Corp0.148021640216400
2024-12-31XTX Topco Ltd0.14650.001721413214130
2024-12-31State Street Corp0.145702130300
2024-12-31HRT FINANCIAL LLC0.13140.000119214192140
2024-12-31Citadel Advisors Llc0.0877012825-21160-62.2628
2024-12-31Tower Research Capital LLC0.03330.00014864-25-0.5114
2024-12-31Morgan Stanley - Brokerage Accounts0.011201631-500-23.4632
2024-12-31Citigroup Inc0.00890129912990
2024-09-30M&R Capital Management Inc0.00230.000133300
2024-12-31Fourth Dimension Wealth, LLC0.00170.00012502500
2024-12-31Group One Trading, LP0.0009012900
2024-12-31Bank of America Corp0.00080117-1-0.8475
2024-12-31JPMorgan Chase & Co0.000701001000
2024-12-31Federation des caisses Desjardins du Quebec0.000506600
2024-12-31UBS Group AG0.000202214.7619
Total 2.90970.0022425397+65848+15.5%

4.9.2. Funds holding Imunon Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-01-31Fidelity Extended Market Index0.53880.000278777-1197-1.4967
2025-02-28Vanguard Institutional Extnd Mkt Idx Tr0.333804880600
2025-01-31Fidelity Total Market Index0.158502316800
2025-01-31Fidelity Series Total Market Index0.129101887100
2024-12-31NT Ext Equity Mkt Idx Fd - L0.11870.00021735612754277.1404
2024-12-31Northern Trust Extended Eq Market Idx0.11870.00021735612754277.1404
2025-01-31Spartan Extended Market Index Pool E0.09010.00021317511979.9933
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T40.02830.0002413641360
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T30.02830.0002413641360
2024-12-31NT Ext Equity Mkt Idx Fd - NL0.02760.0001403500
2024-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.02190.00013198-53-1.6303
2025-01-31Fidelity Nasdaq Composite Index0.02110308200
2025-01-31Spartan Total Market Index Pool E0.01610235900
2024-12-31BNYM Mellon SL Market Completion UC10.00760.00021110201.8349
2024-09-30NT Ext Eq Mkt Indx Fd DC Lending Tier 50.00490.000171010.141
2024-12-31Northern Trust Wilshire 50000.0017024900
2025-01-31Fidelity U.S. Equity Index Ins Trust0.000507300
2025-02-28State St US Extended Mkt Indx NL Cl C0.000101100
2024-06-30SSgA U.S. Total Market Index Strategy005125
Total 1.64580.0017240613+33749+14.0%

5.3. Insider Transactions

Insiders are holding 1.524% of the shares of Imunon Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-08-20Donald P BraunBUY250001.18
2024-08-15Stacy LindborgBUY250000.98
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-12-312024-03-312024-06-302024-09-302024-12-31
Net Debt  -4,2143,376-838-3,079-3,917-5,128-9,0461,148,3391,139,293
Depreciation and Amortization  1413817871854189-742-553



5.2. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets9,717
Total Liabilities5,473
Total Stockholder Equity4,244,298
 As reported
Total Liabilities 5,473
Total Stockholder Equity+ 4,244,298
Total Assets = 9,717

Assets

Total Assets9,717
Total Current Assets8,009
Long-term Assets1,708
Total Current Assets
Cash And Cash Equivalents 5,873
Other Current Assets 2,136
Total Current Assets  (as reported)8,009
Total Current Assets  (calculated)8,009
+/-0
Long-term Assets
Property Plant Equipment 1,658
Long-term Assets Other 50
Long-term Assets  (as reported)1,708
Long-term Assets  (calculated)1,708
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities4,786,131
Long-term Liabilities686,935
Total Stockholder Equity4,244,298
Total Current Liabilities
Short-term Debt 452,810
Accounts payable 1,300
Other Current Liabilities 4,332,021
Total Current Liabilities  (as reported)4,786,131
Total Current Liabilities  (calculated)4,786,131
+/-0
Long-term Liabilities
Capital Lease Obligations 1,139
Long-term Liabilities  (as reported)686,935
Long-term Liabilities  (calculated)1,139
+/- 685,796
Total Stockholder Equity
Common Stock145
Retained Earnings -406,803,044
Other Stockholders Equity 411,047,197
Total Stockholder Equity (as reported)4,244,298
Total Stockholder Equity (calculated)4,244,298
+/-0
Other
Capital Stock145
Cash and Short Term Investments 5,873
Common Stock Shares Outstanding 11,508
Liabilities and Stockholders Equity 9,717
Net Debt 1,139,293
Net Invested Capital 4,244
Net Working Capital 3,223
Property Plant and Equipment Gross 2,855
Short Long Term Debt Total 1,139,293



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-30
> Total Assets 
9,320
1,120
1,110
1,220
820
670
750
500
330
340
400
1,090
1,600
1,200
10,093
10,533
9,118
8,051
6,654
5,244
2,957
4,848
4,281
3,981
2,291
2,640
4,751
7,246
13,128
14,440
24,685
24,284
20,822
17,052
15,390
13,622
17,379
15,909
18,309
15,041
19,318
18,930
16,648
49,430
44,773
39,039
33,850
29,991
25,902
23,688
20,259
16,233
17,743
14,805
11,066
6,560
4,203
2,525
4,808
6,889
23,185
32,649
27,037
26,536
25,409
25,359
47,958
51,015
47,432
45,671
54,710
79,578
73,572
66,695
59,784
60,414
53,659
49,055
43,329
43,515
37,461
30,850
30,799
29,656
26,001
47,514
43,998
49,510
40,912
46,856
45,396
43,587
40,564
38,278
38,937
46,723
37,275
37,527
73,041
83,010
79,469
74,047
64,341
65,328
60,531
43,976
42,106
28,722
24,654
21,918
14,325
9,691
14,391
9,717
9,71714,3919,69114,32521,91824,65428,72242,10643,97660,53165,32864,34174,04779,46983,01073,04137,52737,27546,72338,93738,27840,56443,58745,39646,85640,91249,51043,99847,51426,00129,65630,79930,85037,46143,51543,32949,05553,65960,41459,78466,69573,57279,57854,71045,67147,43251,01547,95825,35925,40926,53627,03732,64923,1856,8894,8082,5254,2036,56011,06614,80517,74316,23320,25923,68825,90229,99133,85039,03944,77349,43016,64818,93019,31815,04118,30915,90917,37913,62215,39017,05220,82224,28424,68514,44013,1287,2464,7512,6402,2913,9814,2814,8482,9575,2446,6548,0519,11810,53310,0931,2001,6001,0904003403305007506708201,2201,1101,1209,320
   > Total Current Assets 
710
550
540
660
640
460
590
340
180
190
260
950
1,400
1,100
9,922
10,372
8,901
7,789
6,393
4,960
2,661
4,500
3,630
3,288
1,510
1,916
4,064
6,543
12,405
13,569
21,523
20,953
17,885
14,148
12,461
10,849
14,648
12,841
13,922
12,376
16,587
16,023
12,014
31,729
26,779
21,424
17,001
27,941
24,178
22,823
19,428
15,093
16,742
14,120
10,430
5,974
3,664
2,027
3,747
6,207
22,214
31,508
25,772
24,935
23,766
23,649
46,415
49,572
46,098
43,762
52,823
50,546
44,499
37,506
30,673
31,465
24,777
20,281
14,682
14,969
9,031
4,513
4,611
3,739
2,774
24,312
20,853
26,342
22,252
28,131
24,861
23,053
20,111
16,235
18,877
26,796
19,905
18,825
56,248
60,310
56,765
51,946
43,866
44,911
40,194
37,155
36,332
26,732
21,725
18,241
12,094
7,646
12,532
8,009
8,00912,5327,64612,09418,24121,72526,73236,33237,15540,19444,91143,86651,94656,76560,31056,24818,82519,90526,79618,87716,23520,11123,05324,86128,13122,25226,34220,85324,3122,7743,7394,6114,5139,03114,96914,68220,28124,77731,46530,67337,50644,49950,54652,82343,76246,09849,57246,41523,64923,76624,93525,77231,50822,2146,2073,7472,0273,6645,97410,43014,12016,74215,09319,42822,82324,17827,94117,00121,42426,77931,72912,01416,02316,58712,37613,92212,84114,64810,84912,46114,14817,88520,95321,52313,56912,4056,5434,0641,9161,5103,2883,6304,5002,6614,9606,3937,7898,90110,3729,9221,1001,400950260190180340590460640660540550710
       Cash And Cash Equivalents 
250
10
10
120
270
30
110
30
60
100
190
870
1,400
800
9,619
10,090
8,820
7,481
6,132
4,630
2,510
4,335
3,530
3,120
929
1,051
3,147
5,501
11,411
12,272
19,427
17,778
13,953
10,484
7,534
5,316
9,255
2,313
1,069
285
1,873
1,033
552
2,364
2,385
2,937
1,543
1,039
818
201
1,920
12,115
12,098
6,923
4,114
2,745
1,824
1,139
1,965
5,380
11,133
20,146
9,122
11,708
8,318
14,991
20,367
6,021
13,170
5,719
4,606
9,597
4,558
12,687
7,614
11,951
7,575
9,265
14,311
12,308
4,184
2,624
4,470
3,629
2,685
11,444
2,285
12,754
3,371
13,354
3,576
6,013
8,522
6,875
5,746
22,654
18,340
17,164
37,759
26,437
25,649
19,586
28,362
26,742
26,938
11,493
10,401
6,611
12,884
5,839
2,347
5,307
10,312
5,873
5,87310,3125,3072,3475,83912,8846,61110,40111,49326,93826,74228,36219,58625,64926,43737,75917,16418,34022,6545,7466,8758,5226,0133,57613,3543,37112,7542,28511,4442,6853,6294,4702,6244,18412,30814,3119,2657,57511,9517,61412,6874,5589,5974,6065,71913,1706,02120,36714,9918,31811,7089,12220,14611,1335,3801,9651,1391,8242,7454,1146,92312,09812,1151,9202018181,0391,5432,9372,3852,3645521,0331,8732851,0692,3139,2555,3167,53410,48413,95317,77819,42712,27211,4115,5013,1471,0519293,1203,5304,3352,5104,6306,1327,4818,82010,0909,6198001,4008701901006030110302701201010250
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,000
9,250
6,500
8,500
8,000
7,000
13,000
8,900
3,000
0
11,603
8,151
7,317
2,346
2,830
4,204
5,695
5,458
2,939
1,379
396
131
134
10,277
10,401
15,472
12,287
14,229
8,038
25,486
42,707
32,039
37,156
47,255
40,171
39,048
24,173
22,396
18,778
16,773
10,800
0
2,160
4,515
1,680
0
0
0
12,724
18,411
13,442
18,580
14,258
20,167
15,702
10,290
7,986
9,887
2,792
0
0
15,000
31,923
28,864
29,803
12,944
15,371
10,414
21,254
20,892
17,400
6,493
9,857
7,462
0
0
0
0007,4629,8576,49317,40020,89221,25410,41415,37112,94429,80328,86431,92315,000002,7929,8877,98610,29015,70220,16714,25818,58013,44218,41112,7240001,6804,5152,160010,80016,77318,77822,39624,17339,04840,17147,25537,15632,03942,70725,4868,03814,22912,28715,47210,40110,2771341313961,3792,9395,4585,6954,2042,8302,3467,3178,15111,60303,0008,90013,0007,0008,0008,5006,5009,2506,0000000000000000000000000000000000000000
       Net Receivables 
160
200
200
200
10
10
30
30
0
0
0
0
0
0
12
2
10
2
3
3
1
1
2
0
84
1
4
227
91
17
1,388
519
644
783
1,599
962
876
766
584
188
876
1,904
1,139
16,033
15,233
15,230
210
15,074
15,068
15,000
15,000
0
0
806
0
0
0
0
50
60
50
0
4
4
307
183
283
206
251
374
340
291
206
210
38
52
25
27
0
0
5
4
0
0
0
54
67
57
77
68
78
66
27
21
1,842
8
0
0
1,846
105
38
109
16
30
30
129
116
80
97
0
0
0
0
0
000009780116129303016109381051,8460081,84221276678687757675400045002725523821020629134037425120628318330744050605000008060015,00015,00015,06815,07421015,23015,23316,0331,1391,9048761885847668769621,5997836445191,3881791227418402113321021200000030301010200200200160
       Inventory 
270
310
310
310
330
350
390
240
40
40
40
40
0
0
22
22
14
14
18
26
0
14
48
123
450
621
752
671
825
918
424
2,460
3,183
2,202
2,689
3,950
4,008
3,326
2,575
2,937
3,045
2,831
2,900
0
0
0
248
0
0
268
0
0
0
0
0
0
0
0
267
50
182
0
149
109
808
246
-283
118
118
112
0
0
0
201
0
0
0
89
0
0
0
89
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,500
2,133
0
0
0
0
0
0
0
00000002,1331,500000000000000000000000008900089000201000112118118-28324680810914901825026700000000268002480002,9002,8313,0452,9372,5753,3264,0083,9502,6892,2023,1832,460424918825671752621450123481402618141422220040404040240390350330310310310270
       Other Current Assets 
30
30
20
30
30
70
60
40
80
50
30
40
0
300
269
259
57
292
134
242
150
150
50
45
47
244
161
144
79
362
283
197
106
679
639
620
510
437
445
2,095
1,984
1,825
423
332
260
257
15,000
226
141
38
161
148
440
695
858
289
460
492
1,302
562
562
962
1,025
805
104
191
562
521
519
402
621
486
687
235
625
684
404
100
372
501
326
115
142
110
89
89
89
89
225
451
1,041
1,272
1,272
1,353
1,401
1,343
1,566
1,661
1,643
1,844
2,213
2,447
2,545
2,768
2,811
2,778
2,790
2,640
2,251
2,545
2,285
2,340
2,220
2,136
2,1362,2202,3402,2852,5452,2512,6402,7902,7782,8112,7682,5452,4472,2131,8441,6431,6611,5661,3431,4011,3531,2721,2721,041451225898989891101421153265013721004046846252356874866214025195215621911048051,0259625625621,3024924602898586954401481613814122615,0002572603324231,8251,9842,09544543751062063967910619728336279144161244474550150150242134292572592693000403050804060703030203030
   > Long-term Assets 
8,610
570
570
560
180
210
160
160
150
150
140
140
200
100
171
161
217
262
261
284
296
348
651
693
781
724
687
703
723
871
3,162
3,330
2,937
2,904
2,929
2,774
2,730
3,068
4,387
2,664
2,731
2,907
4,634
17,701
17,994
17,614
16,849
2,050
1,724
865
831
1,140
1,001
685
636
586
540
499
1,061
682
971
1,141
1,265
1,602
1,643
1,710
1,543
1,442
1,334
1,908
1,887
29,032
29,073
29,188
29,111
28,949
28,883
28,773
28,647
28,546
28,430
26,337
26,188
25,917
23,227
23,203
23,145
23,168
18,660
18,724
20,535
20,534
20,453
22,043
20,060
19,927
17,369
18,702
16,793
22,700
22,704
22,101
20,475
20,417
20,337
6,821
5,774
1,990
2,929
3,677
2,230
2,045
1,859
1,708
1,7081,8592,0452,2303,6772,9291,9905,7746,82120,33720,41720,47522,10122,70422,70016,79318,70217,36919,92720,06022,04320,45320,53420,53518,72418,66023,16823,14523,20323,22725,91726,18826,33728,43028,54628,64728,77328,88328,94929,11129,18829,07329,0321,8871,9081,3341,4421,5431,7101,6431,6021,2651,1419716821,0614995405866366851,0011,1408318651,7242,05016,84917,61417,99417,7014,6342,9072,7312,6644,3873,0682,7302,7742,9292,9042,9373,3303,1628717237036877247816936513482962842612622171611711002001401401501501601602101805605705708,610
       Property Plant Equipment 
30
30
30
30
60
60
30
30
30
30
30
20
-200
-200
71
64
125
173
177
203
189
175
187
183
210
190
176
205
237
389
491
725
706
682
663
615
593
571
642
622
566
515
478
330
305
268
244
212
225
223
207
227
205
537
497
455
418
379
338
479
583
783
908
1,050
1,008
1,115
1,040
1,022
947
833
747
851
1,044
1,170
1,106
1,009
955
855
757
658
544
463
370
257
143
176
175
193
167
185
1,995
1,997
1,952
1,837
1,714
1,584
1,449
1,342
1,335
1,299
1,303
1,168
1,050
992
877
704
2,024
1,940
2,488
2,347
2,180
1,995
1,809
1,658
1,6581,8091,9952,1802,3472,4881,9402,0247048779921,0501,1681,3031,2991,3351,3421,4491,5841,7141,8371,9521,9971,9951851671931751761432573704635446587578559551,0091,1061,1701,0448517478339471,0221,0401,1151,0081,0509087835834793383794184554975372052272072232252122442683053304785155666226425715936156636827067254913892372051761902101831871751892031771731256471-200-200203030303030606030303030
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,939
1,976
1,976
1,976
1,976
1,976
1,976
1,976
1,976
1,976
1,976
1,976
1,976
1,976
1,976
1,976
1,976
1,976
1,976
1,976
1,976
1,976
1,976
1,976
1,976
1,976
1,976
1,976
1,976
1,976
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000001,9761,9761,9761,9761,9761,9761,9761,9761,9761,9761,9761,9761,9761,9761,9761,9761,9761,9761,9761,9761,9761,9761,9761,9761,9761,9761,9761,9761,9761,93900000000000000000000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000006,000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
140
140
140
130
130
150
130
130
120
120
120
110
100
100
100
96
93
89
85
81
77
73
69
65
61
57
53
49
45
41
2,038
36
34
31
29
27
24
0
0
0
0
73
1,648
69
68
66
64
62
60
58
56
0
0
51
0
47
45
43
41
39
38
36
34
32
30
28
26
24
23
0
19
25,819
25,817
25,802
25,813
25,811
25,809
25,802
25,814
25,812
25,810
23,789
23,741
23,685
21,108
21,042
20,994
20,999
16,517
16,305
16,248
16,191
16,134
16,077
16,021
15,964
13,537
13,480
13,423
13,366
13,366
13,366
13,366
13,366
13,366
0
0
0
0
0
0
0
0
0
00000000013,36613,36613,36613,36613,36613,36613,42313,48013,53715,96416,02116,07716,13416,19116,24816,30516,51720,99920,99421,04221,10823,68523,74123,78925,81025,81225,81425,80225,80925,81125,81325,80225,81725,81919023242628303234363839414345470510056586062646668691,6487300002427293134362,038414549535761656973778185899396100100100110120120120130130150130130140140140
       Long-term Assets Other 
400
400
400
400
-10
0
0
0
0
0
-10
10
300
200
0
0
0
0
0
0
30
101
396
445
510
478
458
450
441
441
633
2,570
2,197
2,191
2,236
2,132
2,113
2,497
3,745
2,043
2,165
2,319
2,508
17,302
17,622
17,281
16,541
1,776
1,439
221
221
163
53
0
49
0
0
77
606
163
350
323
0
520
605
567
477
396
364
1,076
1,121
424
236
240
217
152
143
141
100
100
100
109
100
0
0
9
0
0
0
259
315
370
390
333
349
403
407
59
59
6,059
6,059
6,183
6,059
6,059
6,094
4,550
3,750
50
441
50
50
50
50
50
5050505050441503,7504,5506,0946,0596,0596,1836,0596,05959594074033493333903703152590009001001091001001001411431522172402364241,1211,07636439647756760552003233501636067700490531632212211,4391,77616,54117,28117,62217,3022,5082,3192,1652,0433,7452,4972,1132,1322,2362,1912,1972,5706334414414504584785104453961013000000020030010-1000000-10400400400400
> Total Liabilities 
2,570
2,780
3,010
3,470
3,280
2,190
1,860
2,500
2,180
2,330
1,730
490
600
400
602
402
391
482
236
286
288
43
675
718
775
1,422
945
1,094
1,393
987
6,557
5,966
5,761
5,081
5,562
6,190
11,901
12,484
16,248
16,449
21,418
22,130
22,007
10,323
8,903
8,388
6,989
5,313
5,430
3,962
3,850
4,596
5,705
4,770
6,660
4,438
5,046
7,101
9,849
6,399
4,929
6,456
6,675
11,960
12,385
13,397
15,657
18,025
18,290
14,147
14,150
34,219
34,655
33,869
33,080
31,309
28,576
28,669
28,020
27,003
26,889
24,124
24,693
23,008
20,714
20,810
20,388
30,362
25,781
25,995
23,999
24,755
25,104
23,719
22,728
22,515
18,616
18,916
18,081
18,956
20,127
18,251
18,076
18,285
19,180
14,648
15,459
7,207
6,583
8,530
5,825
5,950
6,199
5,473
5,4736,1995,9505,8258,5306,5837,20715,45914,64819,18018,28518,07618,25120,12718,95618,08118,91618,61622,51522,72823,71925,10424,75523,99925,99525,78130,36220,38820,81020,71423,00824,69324,12426,88927,00328,02028,66928,57631,30933,08033,86934,65534,21914,15014,14718,29018,02515,65713,39712,38511,9606,6756,4564,9296,3999,8497,1015,0464,4386,6604,7705,7054,5963,8503,9625,4305,3136,9898,3888,90310,32322,00722,13021,41816,44916,24812,48411,9016,1905,5625,0815,7615,9666,5579871,3931,0949451,422775718675432882862364823914026024006004901,7302,3302,1802,5001,8602,1903,2803,4703,0102,7802,570
   > Total Current Liabilities 
1,350
1,560
1,710
2,100
3,280
2,190
1,860
2,490
2,180
2,320
1,720
490
500
400
598
402
391
482
236
286
272
43
675
718
775
922
945
1,094
1,393
987
3,176
2,727
2,666
2,129
2,752
3,523
3,321
3,896
3,114
3,219
3,508
4,008
3,681
10,288
8,358
8,119
6,898
5,282
5,400
3,934
3,823
4,574
4,133
3,751
4,107
3,749
4,847
6,796
6,867
5,136
4,638
6,152
6,399
6,690
6,606
5,005
7,662
5,710
6,088
4,671
5,247
7,767
9,412
10,091
10,292
9,804
8,429
9,350
9,563
10,406
9,764
8,423
8,843
6,956
5,997
6,200
5,634
6,235
5,800
6,107
5,893
6,649
7,789
7,894
7,430
9,206
5,426
6,753
6,690
5,380
6,475
6,770
6,649
6,891
8,465
10,037
10,418
6,124
5,317
7,391
4,817
5,077
5,442
4,786,131
4,786,1315,4425,0774,8177,3915,3176,12410,41810,0378,4656,8916,6496,7706,4755,3806,6906,7535,4269,2067,4307,8947,7896,6495,8936,1075,8006,2355,6346,2005,9976,9568,8438,4239,76410,4069,5639,3508,4299,80410,29210,0919,4127,7675,2474,6716,0885,7107,6625,0056,6066,6906,3996,1524,6385,1366,8676,7964,8473,7494,1073,7514,1334,5743,8233,9345,4005,2826,8988,1198,35810,2883,6814,0083,5083,2193,1143,8963,3213,5232,7522,1292,6662,7273,1769871,3931,094945922775718675432722862364823914025984005004901,7202,3202,1802,4901,8602,1903,2802,1001,7101,5601,350
       Short-term Debt 
330
330
240
460
1,590
710
180
220
280
110
10
10
100
100
116
115
115
115
112
112
0
0
0
0
0
0
0
0
0
0
542
571
0
0
0
0
0
0
0
0
0
0
0
0
565
677
687
578
408
235
59
0
0
108
112
116
119
123
128
120
89
110
78
494
945
1,410
1,884
1,905
1,945
11
439
1,777
2,701
3,654
3,756
3,865
3,977
4,100
4,201
4,579
3,593
2,561
1,472
0
0
0
0
0
0
0
345
367
956
2,228
2,675
4,796
838
1,550
2,282
458
534
549
517
460
1,044
1,656
2,531
278
471
485
501
516
508
452,810
452,8105085165014854712782,5311,6561,0444605175495344582,2821,5508384,7962,6752,22895636734500000001,4722,5613,5934,5794,2014,1003,9773,8653,7563,6542,7011,777439111,9451,9051,8841,41094549478110891201281231191161121080059235408578687677565000000000000571542000000000011211211511511511610010010101102802201807101,590460240330330
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
671
1,425
2,181
0
0
0
0
0
0
0
00000002,1811,42567100000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
0
100
0
233
106
60
154
55
125
146
35
450
521
495
794
737
802
883
631
1,997
1,466
1,355
819
1,583
1,656
1,622
1,996
1,426
1,263
1,624
2,136
2,132
2,562
1,176
1,830
2,489
1,310
2,237
1,187
1,862
3,139
2,840
2,191
2,304
2,165
2,742
4,549
3,317
3,328
2,773
5,245
3,709
4,306
5,201
2,340
5,278
1,523
2,249
1,452
2,102
3,617
4,436
3,480
4,113
3,203
2,504
2,830
2,765
2,949
3,026
2,879
4,051
3,545
2,806
3,417
3,417
3,703
3,160
3,021
2,586
3,393
3,936
2,863
2,856
2,402
2,168
2,245
2,105
2,109
2,616
2,547
3,474
2,393
3,370
3,587
7,887
2,612
1,827
3,515
2,358
1,969
2,360
1,300
1,3002,3601,9692,3583,5151,8272,6127,8873,5873,3702,3933,4742,5472,6162,1092,1052,2452,1682,4022,8562,8633,9363,3932,5863,0213,1603,7033,4173,4172,8063,5454,0512,8793,0262,9492,7652,8302,5043,2034,1133,4804,4363,6172,1021,4522,2491,5235,2782,3405,2014,3063,7095,2452,7733,3283,3174,5492,7422,1652,3042,1912,8403,1391,8621,1872,2371,3102,4891,8301,1762,5622,1322,1361,6241,2631,4261,9961,6221,6561,5838191,3551,4661,9976318838027377944955214503514612555154601062330100000000000000
       Other Current Liabilities 
1,020
1,230
1,470
1,640
1,690
1,480
1,680
2,270
1,900
2,210
1,710
480
300
300
249
182
216
214
69
50
127
9
225
198
280
129
208
292
510
356
65
690
739
738
598
1,296
1,127
1,328
1,116
1,385
1,313
1,301
977
7,726
69
546
-200
3,394
2,755
1,053
527
1,435
1,293
1,452
1,691
1,468
1,986
2,124
3,423
1,041
1,115
797
2,611
28
459
1,255
1,097
1,783
1,394
2,708
2,206
1,873
1,775
2,456
1,924
2,236
1,448
1,920
2,097
2,379
2,645
2,484
2,820
2,912
2,691
2,283
1,717
2,032
2,140
2,586
2,463
2,389
2,397
2,304
1,399
1,508
1,920
2,459
1,803
2,313
2,825
3,174
2,284
3,788
3,926
4,795
6,095,307
3,233,193
3,019
3,391
1,959
2,592
2,573
4,332,021
4,332,0212,5732,5921,9593,3913,0193,233,1936,095,3074,7953,9263,7882,2843,1742,8252,3131,8032,4591,9201,5081,3992,3042,3972,3892,4632,5862,1402,0321,7172,2832,6912,9122,8202,4842,6452,3792,0971,9201,4482,2361,9242,4561,7751,8732,2062,7081,3941,7831,0971,255459282,6117971,1151,0413,4232,1241,9861,4681,6911,4521,2931,4355271,0532,7553,394-200546697,7269771,3011,3131,3851,1161,3281,1271,29659873873969065356510292208129280198225912750692142161822493003004801,7102,2101,9002,2701,6801,4801,6901,6401,4701,2301,020
   > Long-term Liabilities 
1,220
1,220
1,300
1,370
1,590
710
180
10
10
10
10
10
100
100
4
221
175
269
167
236
15
35
450
521
495
500
737
802
883
631
3,381
3,238
3,095
2,952
2,810
2,667
8,579
8,588
13,134
13,229
17,910
18,122
18,326
35
544
269
92
31
30
28
27
22
1,573
1,019
2,552
689
199
305
2,981
1,264
291
303
277
5,270
5,779
8,392
7,995
12,315
12,203
9,476
8,903
26,452
25,243
23,778
22,788
21,505
20,147
19,319
18,457
16,596
17,124
15,701
15,850
16,051
14,717
14,610
14,754
24,127
19,981
19,888
18,106
18,107
17,315
15,825
15,298
13,309
13,190
12,163
11,391
13,576
13,652
11,481
11,428
11,395
10,716
4,611
5,041
1,083
1,266
1,139
1,008
873
758
686,935
686,9357588731,0081,1391,2661,0835,0414,61110,71611,39511,42811,48113,65213,57611,39112,16313,19013,30915,29815,82517,31518,10718,10619,88819,98124,12714,75414,61014,71716,05115,85015,70117,12416,59618,45719,31920,14721,50522,78823,77825,24326,4528,9039,47612,20312,3157,9958,3925,7795,2702773032911,2642,9813051996892,5521,0191,5732227283031922695443518,32618,12217,91013,22913,1348,5888,5792,6672,8102,9523,0953,2383,3816318838027375004955214503515236167269175221410010010101010101807101,5901,3701,3001,2201,220
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,470
5,396
5,396
5,396
5,396
0
0
0
0
0
0
0
0
0
0000000005,3965,3965,3965,3967,4700000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
6,760
-1,650
-1,910
-2,250
-2,460
-1,520
-1,110
-1,990
-1,850
-1,990
-1,330
600
1,000
800
9,491
10,131
8,726
7,568
6,418
4,957
2,669
4,805
3,606
3,263
1,516
1,218
3,806
6,152
11,735
13,453
18,128
18,318
15,061
11,971
9,828
7,432
5,478
3,425
2,061
-1,408
-2,100
-3,201
-5,360
39,107
35,870
30,651
26,861
24,678
20,472
19,726
16,409
11,637
12,038
10,036
4,406
2,122
-843
-4,576
-5,040
489
18,256
26,194
20,362
14,576
13,024
11,962
32,301
32,990
29,141
31,524
40,559
45,359
38,917
32,825
26,704
29,105
25,083
20,386
15,309
16,512
10,572
6,726
6,106
6,649
5,287
26,705
23,610
19,148
15,131
20,861
21,397
18,832
15,460
14,559
16,209
24,208
18,659
18,611
54,960
64,054
59,341
55,796
46,265
47,042
41,351
29,328
26,647
21,515
18,072
13,388
8,500
3,741
8,192
4,244,298
4,244,2988,1923,7418,50013,38818,07221,51526,64729,32841,35147,04246,26555,79659,34164,05454,96018,61118,65924,20816,20914,55915,46018,83221,39720,86115,13119,14823,61026,7055,2876,6496,1066,72610,57216,51215,30920,38625,08329,10526,70432,82538,91745,35940,55931,52429,14132,99032,30111,96213,02414,57620,36226,19418,256489-5,040-4,576-8432,1224,40610,03612,03811,63716,40919,72620,47224,67826,86130,65135,87039,107-5,360-3,201-2,100-1,4082,0613,4255,4787,4329,82811,97115,06118,31818,12813,45311,7356,1523,8061,2181,5163,2633,6064,8052,6694,9576,4187,5688,72610,1319,4918001,000600-1,330-1,990-1,850-1,990-1,110-1,520-2,460-2,250-1,910-1,6506,760
   Common Stock
410
250
260
270
290
340
360
370
400
420
460
510
500
500
606
640
644
645
763
767
769
853
897
905
924
975
1,125
1,244
1,431
1,480
1,580
1,606
1,607
1,607
1,609
1,609
1,609
1,609
107
107
107
107
108
108
108
108
108
108
108
108
108
109
129
129
130
130
135
141
146
205
274
339
339
339
355
380
515
618
137
137
173
201
201
201
201
231
231
234
235
258
261
312
555
59
84
173
177
177
179
188
197
210
220
233
293
332
362
407
750
866
866
58
58
71
71
74
91
93
94
94
94
94
145
145
145145949494949391747171585886686675040736233229323322021019718817917717717384595553122612582352342312312012012012011731371376185153803553393393392742051461411351301301291291091081081081081081081081081081071071071071,6091,6091,6091,6091,6071,6071,6061,5801,4801,4311,2441,125975924905897853769767763645644640606500500510460420400370360340290270260250410
   Retained Earnings -406,803,044-402,746-397,900-393,112-388,183-383,295-379,818-374,259-368,668-355,435-349,287-343,244-332,770-328,548-323,138-317,689-312,000-308,988-300,917-295,574-290,517-287,414-281,937-276,033-273,665-279,146-274,489-266,259-261,782-257,101-251,430-246,540-241,380-235,673-228,755-224,025-218,130-212,489-208,074-202,253-195,074-188,501-181,512-174,744-169,287-165,303-155,698-156,119-150,877-142,620-136,598-130,473-124,222-118,091-111,675-104,716-100,938-95,613-90,895-88,265-82,120-79,790-75,132-70,541-66,924-65,990-61,650-59,220-55,138-52,248-48,630-92,844-90,487-89,400-88,409-84,686-82,903-80,778-78,825-76,421-74,217-71,080-67,769-66,298-60,232-57,278-53,547-50,648-45,808-43,820-41,704-39,045-35,282-33,605-31,017-29,587-27,822-26,447-24,861-23,898-22,700-21,900-21,050-20,630-20,010-19,460-18,790-17,180-16,120-15,260-14,120-13,260-12,650-12,210
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
18,560
10,750
11,090
11,600
12,720
14,480
15,920
16,640
17,420
17,820
19,060
21,360
22,600
23,200
28,083
29,659
29,429
29,655
34,192
34,241
34,534
38,312
40,823
41,364
42,076
43,470
50,925
56,307
67,582
72,205
82,846
84,481
84,535
84,581
85,183
85,245
85,299
85,424
86,649
87,661
88,013
88,054
88,302
88,353
88,762
86,383
86,704
86,227
86,376
87,314
87,635
87,477
92,537
91,958
92,462
92,889
94,678
96,240
99,511
111,938
136,230
150,353
150,773
151,151
155,421
162,586
188,063
188,283
194,613
200,718
215,158
226,682
227,243
227,714
228,763
236,953
237,342
238,286
241,277
245,009
245,984
250,306
254,718
260,760
265,159
288,324
289,725
293,464
294,077
294,308
297,146
300,464
302,619
304,800
311,486
324,785
327,285
330,204
371,897
386,329
387,022
388,516
389,510
396,328
396,741
397,895
400,691
401,079
401,252
401,416
401,385
401,548
410,793
411,047,197
411,047,197410,793401,548401,385401,416401,252401,079400,691397,895396,741396,328389,510388,516387,022386,329371,897330,204327,285324,785311,486304,800302,619300,464297,146294,308294,077293,464289,725288,324265,159260,760254,718250,306245,984245,009241,277238,286237,342236,953228,763227,714227,243226,682215,158200,718194,613188,283188,063162,586155,421151,151150,773150,353136,230111,93899,51196,24094,67892,88992,46291,95892,53787,47787,63587,31486,37686,22786,70486,38388,76288,35388,30288,05488,01387,66186,64985,42485,29985,24585,18384,58184,53584,48182,84672,20567,58256,30750,92543,47042,07641,36440,82338,31234,53434,24134,19229,65529,42929,65928,08323,20022,60021,36019,06017,82017,42016,64015,92014,48012,72011,60011,09010,75018,560



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-19,132,446
Operating Income-19,132,446-19,132,446
 
Operating Expense (+$)
Research Development11,639,411
Selling General Administrative7,493,035
Selling And Marketing Expenses0
Operating Expense19,132,44619,132,446
 
Net Interest Income (+$)
Interest Income450
Interest Expense-0
Other Finance Cost-0
Net Interest Income450
 
Pretax Income (+$)
Operating Income-19,132,446
Net Interest Income450
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-18,620,242-19,644,650
EBIT - interestExpense = 0
-18,620,242
-18,620,242
Interest Expense0
Earnings Before Interest and Taxes (EBIT)0-18,620,242
Earnings Before Interest and Taxes (EBITDA)-19,132,446
 
After tax Income (+$)
Income Before Tax-18,620,242
Tax Provision-0
Net Income From Continuing Ops-18,620-18,620,242
Net Income-18,620,242
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net512,204-450
 

Technical Analysis of Imunon
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Imunon. The general trend of Imunon is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Imunon's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Imunon Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Imunon Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.18 < 1.21 < 1.39.

The bearish price targets are: 0.78 > 0.78 > 0.7609.

Know someone who trades $IMNN? Share this with them.πŸ‘‡

Imunon Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Imunon Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Imunon Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Imunon Inc.

Imunon Inc Daily Moving Average Convergence/Divergence (MACD) ChartImunon Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Imunon Inc. The current adx is .

Imunon Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Imunon Inc.

Imunon Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Imunon Inc.

Imunon Inc Daily Relative Strength Index (RSI) ChartImunon Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Imunon Inc.

Imunon Inc Daily Stochastic Oscillator ChartImunon Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Imunon Inc.

Imunon Inc Daily Commodity Channel Index (CCI) ChartImunon Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Imunon Inc.

Imunon Inc Daily Chande Momentum Oscillator (CMO) ChartImunon Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Imunon Inc.

Imunon Inc Daily Williams %R ChartImunon Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Imunon Inc.

Imunon Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Imunon Inc.

Imunon Inc Daily Average True Range (ATR) ChartImunon Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Imunon Inc.

Imunon Inc Daily On-Balance Volume (OBV) ChartImunon Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Imunon Inc.

Imunon Inc Daily Money Flow Index (MFI) ChartImunon Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Imunon Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-12-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-12-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-12-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-12-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-02ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-03RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-01-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-01-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-02-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-24STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-25BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-24BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-25RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-26BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-04-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-14STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Imunon Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Imunon Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.870
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Imunon with someone you think should read this too:
  • Are you bullish or bearish on Imunon? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Imunon? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Imunon Inc

I send you an email if I find something interesting about Imunon Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Imunon Inc.

Receive notifications about Imunon Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.